Sector ratings bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 05/12/2025 GMT			5-day change	1st Jan Change
104.80 ^EUR	+0.58%		-2.87%	+1.26%

12-04	BioMérieux Launches Two Dedicated Equine Tests
11-10	UBS Maintains Buy Rating on BioMérieux, Confirms Price Target

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
BIOMÉRIEUX	14.39B		A
GUARDANT HEALTH, INC.	13.14B	-	AA	-		-
CARIS LIFE SCIENCES, INC.	8.14B	-	-	-		-	-
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	6.65B		BBB
LANTHEUS HOLDINGS, INC.	4.2B		BBB			-
DIASORIN S.P.A.	3.91B		BBB
AUTOBIO DIAGNOSTICS CO., LTD.	2.92B		CCC			-
ANDON HEALTH CO., LTD.	2.43B	-	-	-	-	-	-	-
10X GENOMICS, INC.	2.25B	-	BBB	-		-
BEIJING HOTGEN BIOTECH CO., LTD.	2.17B	-	-	-		-	-	-
VITROLIFE AB	2.03B		A
VCANBIO CELL & GENE ENGINEERING CORP., LTD	1.85B	-	-	-		-	-	-
SANSURE BIOTECH INC.	1.63B		-			-
GUANGZHOU WONDFO BIOTECH CO.,LTD	1.37B		-			-
DAAN GENE CO., LTD.	1.28B	-	-	-	-	-	-	-
SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.	1.28B	-	-	-		-	-
AMOY DIAGNOSTICS CO., LTD.	1.22B		-
CASTLE BIOSCIENCES, INC.	1.13B		AAA			-
BEIJING STRONG BIOTECHNOLOGIES,INC.	1.13B	-	-	-		-	-
MACCURA BIOTECHNOLOGY CO.LTD	982M	-	-	-		-
Average	3.71B		A
Weighted average by Cap.			A